This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

NCI Reports Third Quarter 2013 Financial And Operating Results

NCI, Inc. (NASDAQ: NCIT), a leading provider of information technology (IT), engineering, logistics, and professional services and solutions to U.S. Federal Government agencies, today announced its financial and operating results for the third quarter ended September 30, 2013.

Third quarter 2013 revenue was at the high end of management’s guidance range issued last quarter. Diluted EPS exceeded the high end of guidance by $0.04.

Third Quarter 2013 Results

For the three months ended September 30, 2013, total revenue decreased by 11.9%, or $10.5 million, to $77.9 million, compared with the same period a year ago. The decrease was due to $3.1 million of lower revenue attributable to services provided under NCI’s PEO Soldier contract as well as $7.4 million of reductions in scope of work, including the impact of sequestration, and the expiration of certain task orders and contracts, partially offset by revenue from new awards and growth on existing programs. During the third quarter of 2013, NCI’s PEO Soldier program accounted for 14% of revenue compared with 16% of revenue for the same period in 2012.

General and administrative expenses decreased 6.9%, or $0.4 million, for the three months ended September 30, 2013, compared with the same period a year ago. The decrease was primarily due to lower compensation expense as a result of reduced headcount, partially offset by continued investment in business development initiatives.

GAAP operating income for the third quarter of 2013 was $3.5 million compared with a GAAP operating loss for the third quarter of 2012 of $91.7 million. GAAP operating income for the third quarter of 2013 included a $0.9 million gain from the resolution of a purchase contingency related to the AdvanceMed acquisition in April 2011. GAAP operating loss for the third quarter of 2012 included costs resulting from a goodwill impairment charge of $92.8 million and a cash tender offer of approximately $2.3 million for certain out-of-the-money stock options held by current and former NCI employees. Excluding the effects of these items, NCI reported adjusted operating income of $2.6 million for the third quarter of 2013 and $3.4 million for the third quarter of 2012 1. Adjusted operating margin was 3.3% for the third quarter of 2013 and 3.8% for the third quarter of 2012. Adjusted operating income and margin for the third quarter of 2013 decreased due to lower revenue and the reduced absorption of indirect costs on the lower revenue base, respectively.

GAAP net income for the third quarter of 2013 was $2.0 million compared with a GAAP net loss for the third quarter of 2012 of $55.2 million. Excluding the impact of the purchase contingency gain, adjusted net income for the third quarter of 2013 was $1.4 million. Excluding the impact of the impairment charge and stock option tender offer, adjusted net income for the third quarter of 2012 was $1.8 million. The decrease in adjusted net income year over year is attributable to the factors affecting operating income, partially offset by lower interest expense.

1 of 5

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 16,943.81 +28.74 0.17%
S&P 500 1,967.57 +2.89 0.15%
NASDAQ 4,415.49 +19.2860 0.44%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto
Advertising Partners

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs